TELA Bio Files Definitive Proxy Statement for 2025 Annual Meeting
Ticker: TELA · Form: DEF 14A · Filed: Apr 17, 2025 · CIK: 1561921
| Field | Detail |
|---|---|
| Company | Tela Bio, Inc. (TELA) |
| Form Type | DEF 14A |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: TELA
TL;DR
TELA Bio's proxy statement is out for the May 28th meeting - vote on directors & auditors.
AI Summary
TELA Bio, Inc. filed its definitive proxy statement (DEF 14A) on April 17, 2025, for its annual meeting on May 28, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key areas include the election of directors and the ratification of the independent registered public accounting firm.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and important corporate matters, impacting the company's strategic direction and governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that outlines standard corporate governance and voting matters, not indicating new or unusual risks.
Key Players & Entities
- TELA Bio, Inc. (company) — Registrant
- April 17, 2025 (date) — Filing Date
- May 28, 2025 (date) — Annual Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the definitive proxy statement for TELA Bio, Inc.'s annual meeting of shareholders, outlining matters to be voted upon.
When is TELA Bio, Inc.'s annual meeting scheduled?
TELA Bio, Inc.'s annual meeting is scheduled for May 28, 2025.
Who is the filer of this proxy statement?
TELA Bio, Inc. is the registrant and the filer of this proxy statement.
What is the filing date of this document?
This definitive proxy statement was filed on April 17, 2025.
What are the typical items voted on in a DEF 14A filing?
Typical items voted on include the election of directors and the ratification of the independent registered public accounting firm, as indicated by the structure of the proxy statement.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 17, 2025 regarding TELA Bio, Inc. (TELA).